Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Also Read: Medicare To Reimburse Guardant Health’s Shield Colorectal Cancer Test ... is a blood test that uses epigenomic (methylation) analysis to detect circulating tumor DNA (ctDNA), a ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its ...

A new CRISPR treatment using patient's cells and a knock out of CISH cured woman's Stage 4 incurable colorectal cancer. 1st ...

Colorectal cancer has increased significantly over the past 20 years among adults under 50. Now scientists may have identified a potential factor in the rise: a toxin called colibactin. Exposure to ...